Gene · 710
Papers4,575
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,881 to 1,900 of 4,575
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Structure and functional analysis of the Legionella pneumophila chitinase ChiA reveals a novel mechanism of metal-dependent mucin degradation. | PLoS Pathog | 2020 | 32365117 | PubTator, text mining | PubMed |
| A first of its kind quantitative functional C1-esterase inhibitor lateral flow assay for hereditary angioedema point-of-care diagnostic testing. | Int Immunopharmacol | 2020 | 32361670 | PubTator, text mining | PubMed |
| Identification of aberrantly methylated differentially expressed genes targeted by differentially expressed miRNA in osteosarcoma. | Ann Transl Med | 2020 | 32355817 | PubTator, text mining | PubMed |
| Membrane Phospholipids and Polyphosphates as Cofactors and Binding Molecules of SERPINA12 (vaspin). | Molecules | 2020 | 32344508 | PubTator, text mining | PubMed |
| COVID-19 and its implications for thrombosis and anticoagulation. | Blood | 2020 | 32339221 | PubTator, text mining | PubMed |
| Antibody-induced vascular inflammation skews infiltrating macrophages to a novel remodeling phenotype in a model of transplant rejection. | Am J Transplant | 2020 | 32320528 | PubTator, text mining | PubMed |
| Commentary: Bradykinin-Mediated Angioedema: An Update of the Genetic Causes and the Impact of Genomics. | Front Genet | 2020 | 32318097 | PubTator, text mining | PubMed |
| New Insights in the Pathogenesis and Therapy of Cold Agglutinin-Mediated Autoimmune Hemolytic Anemia. | Front Immunol | 2020 | 32318071 | PubTator, text mining | PubMed |
| Eculizumab Treatment for Postpartum HELLP Syndrome and aHUS-Case Report. | Front Immunol | 2020 | 32308654 | PubTator, text mining | PubMed |
| Repetitive Mild Traumatic Brain Injury and Transcription Factor Modulation. | J Neurotrauma | 2020 | 32292111 | PubTator, text mining | PubMed |
| Advances in Hereditary Angioedema: The Prevention of Angioedema Attacks With Subcutaneous C1-Inhibitor Replacement Therapy. | J Infus Nurs | 2020 | 32287168 | PubTator, text mining | PubMed |
| Proteomic analysis of intermediate uveitis suggests myeloid cell recruitment and implicates IL-23 as a therapeutic target. | Am J Ophthalmol Case Rep | 2020 | 32274442 | PubTator, text mining | PubMed |
| Current status of cell-based therapies for respiratory virus infections: applicability to COVID-19. | Eur Respir J | 2020 | 32265310 | PubTator, text mining | PubMed |
| The common motives for appendectomy in Hail Region Saudi Arabia. | AIMS Public Health | 2020 | 32258194 | PubTator, text mining | PubMed |
| Designation of Autoinflammatory Skin Manifestations With Specific Genetic Backgrounds. | Front Immunol | 2020 | 32256502 | PubTator, text mining | PubMed |
| Experience with Intravenous Plasma-Derived C1-Inhibitor in Pregnant Women with Hereditary Angioedema: A Systematic Literature Review. | J Allergy Clin Immunol Pract | 2020 | 32251736 | PubTator, text mining | PubMed |
| A focus on the use of subcutaneous C1-inhibitor for treatment of hereditary angioedema. | Expert Rev Clin Immunol | 2020 | 32237900 | PubTator, text mining | PubMed |
| Joint modelling of longitudinal and time-to-event data: an illustration using CD4 count and mortality in a cohort of patients initiated on antiretroviral therapy. | BMC Infect Dis | 2020 | 32228483 | PubTator, text mining | PubMed |
| Drivers and regulators of humoral innate immune responses to infection and cancer. | Mol Immunol | 2020 | 32199212 | PubTator, text mining | PubMed |
| Clinical Characteristics and Safety of Plasma-Derived C1-Inhibitor Therapy in Children and Adolescents with Hereditary Angioedema-A Long-Term Survey. | J Allergy Clin Immunol Pract | 2020 | 32198128 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/710/papers?page=95